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Abstract — N-Alkyloxazolidines react in a multicomponent reaction with carboxylic acids and isocyanides to
give N-acyloxyethylamino acid amides. The previously reported reaction conditions were improved using a
design of experiments approach (DoE). Under the optimized conditions, good yields of the N-acyloxyethylamino
acid amide products are obtained both via a three or four component approach from N-alkylethanolamines,
aldehydes/ketones, isocyanides and carboxylic acids. The reaction of oxazolidines without a nitrogen substituent
was found to give either the expected Ugi products or the N-acyloxyethylamino acid amides depending on the
choice of reaction conditions. Optimised reaction conditions were also developed for the ring-expansion of
oxazolidines to morpholin-2-ones via reaction with an isocyanide followed by hydrolysis. The mechanistic
pathway of the multicomponent reaction was briefly investigated using an 18O labelling experiment. The
carboxylic acid component can be replaced by a range of other acidic nucleophiles including thiobenzoic acid,
thiophenol or 5-phenyl tetrazole, which are incorporated via an alternative pathway. These latter reactions can
also be applied to 2-aminotetrahydrofurans, 2-aminotetrahydropyrans or 4-hydroxybut-2-one, further extending
the structural diversity of the multicomponent reaction products.
Keywords Multicomponent reactions; Isocyanides; Design of Experiments; Oxazolidines; Ring-opening
reactions
Multicomponent reactions (MCRs) are convergent reactions between three or more reactants in which all or most
of the atoms in the starting materials form part of the final product.1 They are inherently atom economical
processes in which relatively complex products can be obtained in a one-pot reaction from simple starting
materials, and thus exemplify many of the desired features of an ‘ideal synthesis’. Within this framework,
isocyanide based multicomponent reactions (IMCRs) have provided a wealth of highly useful sequences for the
assembly of compound libraries of particular interest to the pharmaceutical industry, and those which incorporate
amino acid or hydroxyacid motifs through the use of the well known Ugi2 and Passerini3 reactions have proven
to be especially valuable. The replacement of the carbonyl component in these reactions with a cyclic acetal unit
could provide access to alternative multicomponent pathways, although reactions have, to date, been limited to
simple isocyanide insertion into one of the C-O bonds.4 However, the application of bis-secondary diamines,5
N,O-acetals6 and glycolaldehyde dimer7 in novel IMCRs has been reported. Numerous reviews in recent years on
the development and application of isocyanide based multicomponent reactions provide ample evidence of the
burgeoning interest in this rapidly evolving research area, partly fuelled by the unique intellectual challenges
posed by their design.8
We recently reported a novel three-component reaction (3-CR) between N-alkyl oxazolidines, isocyanides and
carboxylic acids (Scheme 1).6 As part of our ongoing investigations into isocyanide based multicomponent
reactions (IMCR), we now describe, in full detail, the optimisation of this reaction via a design of experiments
(DoE) approach, enabling the reaction to be carried out successfully as a four component reaction in which the
oxazolidine is generated in situ from a carbonyl compound and an ethanolamine. We also describe a mechanistic
study and the extension of these multicomponent reactions to a wider range of N,O-acetals and nucleophilic
components.
1. Results and Discussion.
Three-Component MCR of Oxazoldines, Isocyanides and Carboxylic Acids.
Initial reactions were carried out using an N-alkyloxazolidine, an isocyanide and a carboxylic acid with 10%
TsOH as catalyst (Scheme 1), and gave reasonable to good yields of the N-acyloxyethylamino acid amides
(Table 1) when the reactions were carried out at reflux in MeCN.6 A wide variety of oxazolidines,9 isocyanides
and carboxylic acids were well tolerated and this reaction gives a complimentary structural skeleton to the
ubiquitous Ugi and Passerini reactions. Thus, oxazoldines derived from both aromatic and aliphatic aldehydes
bearing a variety of nitrogen substituents could be employed, together with alkyl and aryl isocyanides and alkyl
4or benzoic acids. The yields were good in most cases, although reactions with aryl isocyanides or those with a
bulky nitrogen substitutent gave lower conversions. The reaction was extremely slow at room temperature and in
the absence of an acid catalyst.
Scheme 1
Table 1. Three-component reactions of oxazolidines, isocyanides and carboxylic acids.
Oxazolidinone R4 R5 Yield Product
1a tBu Ph 66% 4a
1a tBu Et 64% 4b
1a cC6H11 Ph 71% 4c
1a iPr Ph 73% 4d
1b tBu Ph 80% 4e
1b tBu Et 78% 4f
1b cC6H11 Ph 48% 4g
1b tBu 2-(3-
indole)ethy
l
44% 4h
1b 2,6-
dimethylpheny
l
Et 42% 4i
1b 2-chloro-6-
methylphenyl
Ph 29% 4j
1c tBu Ph 68% 4k
1d tBu Ph 47% 4l
1e tBu Ph 44% 4m
1f tBu Ph 63% 4n
1g tBu Me 20% 4o
1a tBu Me 54% 4pa
a The reaction was carried out in iPrOH (see Scheme 7).
Four-component MCR via in situ Oxazolidine Formation
After the successful development of the three-component reaction between an N-alkyloxazolidine, isocyanide
and carboxylic acid (Scheme 1), we reasoned that an in-situ preparation of the N-alkyloxazolidine in the
presence of an isocyanide and carboxylic acid – a four-component reaction (4-CR) – should also be feasible. A
brief study indicated that oxazolidine formation was essentially complete under the reaction conditions after 30
minutes. Unfortunately, the reaction between n-heptanal, N-methylethanolamine, tert-butyl isocyanide and
benzoic acid gave a disappointing 13% yield of the desired four-component product 4e (Scheme 2). Lactone 5a
was isolated as the major product (25%) from this reaction. Close examination of the NMR spectra of the crude
reaction mixtures of the earlier three-component reactions indicated that small quantities of morpholin-2-one
products were also present, presumably due to traces of water in the reaction mixture.
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When the reaction was carried out in the absence of the carboxylic acid, 5a was obtained in 36% yield. A
possible mechanism for this bifurcated reaction pathway is shown in Scheme 3. Trapping of the iminium ion by
the isocyanide leads to nitrilium cation 7 which can be expected to exist in equilibrium with cyclic iminoether 8.
Nucleophilic attack of a carboxylic acid on nitrilium cation 7 will lead to the multicomponent product 4 after
subsequent acyl transfer in intermediate 9 (Path A). Alternatively, attack of the carboxylic acid on 8 could lead
directly to the multicomponent product 4 via nucleophilic ring opening (Path B).10 Finally, competing hydrolysis
of the cyclic intermediate 8 will lead to the morpholin-2-one product 5. The 4-CR presumably leads to the
formation of a significant amount of morpholin-2-one due to the generation of one equivalent of water during the
oxazolidine formation step.
Scheme 3
1.1. Design of Experiments (DoE) Optimisation of the Multicomponent Reaction.
At this stage in our investigation, we decided to use a Design of Experiments (DoE) approach11 in order to
improve the yield of both the three and four component reactions. Initially we looked at developing conditions
for the 3-CR, with the intention of being able to subsequently carry out the reaction as a four-component
reaction, whilst minimising the formation of 5. DoE selects a wide ranging and diverse set of experiments in
which the factors are independent of each other yet may be varied simultaneously. This results in a causal
predictive model, which quantifies the importance of each factor plus any factor-factor interactions. DoE has
seen extensive use in process chemistry in recent years and may be both more thorough and efficient than
classical one variable at a time (OVAT) methods.11 The 3-CR to produce 4m (Scheme 4) was chosen as a good
substrate for the DoE process as it resulted in a moderate yield of 44%, giving plenty of scope for yield
improvement, as well as a good chromophore for HPLC UV detection. MODDE 7 software was used to design
a set of reactions. The factors chosen for variation and the levels employed are shown in Table 2. The effect of
the factors on the yield of both 4m and 5b was investigated.
Scheme 4.
1.1.1. Design of Experiments (DoE) #1
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6We embarked upon a mixed level fractional factorial experimental design (resolution III), with one factor at four
levels and five factors at two levels allowing main factors to be assessed for importance, this was carried out as
16 experiments plus four control experiments (Table 3). Yields of 4m and 5b were determined by HPLC UV
peak area integration relative to 1,1,1-trifluorotoluene internal standard.
Table 2. Variables considered, with levels employed in design (DOE #1).
Variable (-) 0 (+)
A Temperature (oC) 60 N/A 80
B Solvent Concentration (M) 0.2 0.3 0.4
C Benzoic Acid (equivalents) 1 1.25 1.5
D Acid Catalyst (mol%) 2 6 10
E Isocyanide (equivalents) 1 1.25 1.5
F Solvent Type (4 types)a - - -
a (i)-Anisole (ii)-EtOAc (iii)-iPrOH (iv)-MeCN
The data was analysed using MODDE 7 software by a partial least squares fitting model (PLS). This resulted
in two models, the first for 4m where R2 = 0.922 and Q2 = 0.844 and a second model for 5b where R2 = 0.897
and Q2 = 0.711 respectively.
Table 3 Experimental plan and results (DOE #1).
# A B C D E F Yield 4m Yield 5b
1 - - - + + i 48% 26%
2 + - - + + ii 44% 23%
3 - - - - - iii 65% 18%
4 + - - - - iv 67% 30%
5 + + - - + i 38% 18%
6 - + - - + ii 36% 16%
7 + + - + - iii 64% 30%
8 - + - + - iv 61% 36%
9 + - + + - i 47% 27%
10 - - + + - ii 38% 17%
11 + - + - + iii 74% 14%
12 - - + - + iv 68% 21%
13 - + + - - i 54% 24%
14 + + + - - ii 33% 13%
15 - + + + + iii 68% 25%
16 + + + + + iv 57% 29%
17 - 0 0 0 0 ii 41% 18%
18 - 0 0 0 0 ii 42% 18%
19 + 0 0 0 0 ii 40% 19%
20 + 0 0 0 0 ii 38% 18%
The data from the models is viewed as a scaled and centered coefficient plot where the sign and size of each
coefficient bar shows the relative effect on the yield and thus the relative importance of the factor in the model.
7Graph 1. Scaled and centred coefficients for 4m yield.
For the formation of 4m, temperature and equivalents of benzoic acid, TsOH and isocyanide had no statistical
effect within the parameters investigated. Graph 1 shows that choice of solvent is the most significant factor
affecting the yield of 4m, with isopropanol and to a lesser degree acetonitrile, being superior. Concentration of
reactants had a smaller effect within the range investigated.
Graph 2. Scaled and centred coefficients for 5b yield.
Graph 2 indicates that the factors affecting the yield of lactone 5b are solvent and TsOH loading. The use of
acetonitrile as solvent and a higher loading of TsOH results in an increased yield of 5b. The two models together
reveal that for a cleaner higher yielding preparation of 4m in the presence of some water, isopropanol should be
selected as solvent, since it favours the formation of 4m and disfavours the formation of 5b. A lower loading of
TsOH is also desirable, as it has no effect on the yield of 4m, whilst a higher level favours the formation of side
product 5b. The lower temperature of 60 °C may also be used, as there is no benefit indicated by the use of a
higher temperature. However it should again be noted that initial work showed that this reaction was very slow at
room temperature or in the absence of an acid catalyst. The new conditions obtained from the DoE study were
expected to reduce the amount of lactone 5b produced by hydrolysis of intermediate 8. We therefore
investigated whether we could apply these conditions to the four-component reaction. Initial experiments to
determine the rapidity of the oxazolidine formation in isopropanol were encouraging, with over 80% conversion
to the oxazolidine observed within 30 minutes under the reaction conditions. Satisfyingly when the 4-CR was
attempted between an ethanolamine, aldehyde, isocyanide and carboxylic acid, a yield akin to the 3-CR was
obtained in most cases (Table 4).
Table 4. Four-component reactions of aminoalcohols, aldehydes, isocyanides and carboxylic acids.
R1 R2 R3 R4 R5 Yield Product
4-Me-C6H4 H Me tBu Ph 68% 4a
nC6H13 H Me tBu Ph 56% 4e
4-MeO-C6H4 H Me tBu Ph 66% 4k
4-O2N-C6H4 H Me tBu Ph 30% 4l
nC6H13 H Me cC6H11 Ph 43% 4g
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Scheme 5
The new reaction conditions were also applied to the synthesis of medium ring products in moderate yield via
incorporation of the bifunctional acid-aldehyde components 10 and 11 (Scheme 5).12 These reactions were
unsuccessful at high temperature, but the multicomponent reaction products 12-14 were obtained in moderate
yield on stirring the reactions for prolonged periods at room temperature.
1.3. Design of Experiments (DoE) #2 Morpholinone synthesis.
We then directed our attention to optimizing the conditions for the ring expansion of oxazolidines to
morpholinones by the reaction of an oxazolidine with t-butyl isocyanide (Scheme 6). Model 2 in DoE #1 (Graph
2) indicates that the formation of 5b is favoured by a polar aprotic solvent (acetonitrile) and a higher loading of
TsOH. These factors were further investigated using a second design of experiments (DoE) process. The
selected variables in this study were solvent type (2 levels), TsOH acid catalyst loading and isocyanide loading
(Table 5). Preliminary studies of polar aprotic solvents suggested sulfolane and DMSO to be superior solvents
to MeCN for the study; DMF was unsuitable. A full factorial experimental design (resolution V) with three
factors with each at two levels, allowing main factors and interaction between factors to be assessed for
importance, was carried out as eight experiments plus two control experiments (Table 6). Yields of 5b were
determined by HPLC UV peak area integration relative to 1,1,1-trifluorotoluene internal standard at the three
reaction times given in Table 6.
Table 5. Variables considered, with levels employed in DOE #2.
Variable (-) 0 (+)
A Acid Catalyst (mol%) 10 30 50
B Isocyanide (equivalents) 1 1.25 1.5
C Solvent Type (2 types)a - - -
a (i)-DMSO (ii)-Sulfolane
9Table 6. Experimental plan and yields of 5b (DOE #2).
# A B C 4h 22h 44h
1 - - i 0% 15% 26%
2 - - ii 0% 3% 4%
3 + - i 4% 26% 38%
4 + - ii 8% 23% 29%
5 - + i 0% 16% 27%
6 - + ii 0% 7% 9%
7 + + i 7% 33% 51%
8 + + ii 12% 24% 36%
9 0 0 i 4% 28% 41%
10 0 0 i 5% 30% 43%
The data was analysed to give a model where R2 = 0.892 and Q2 = 0.781.
Graph 3. Scaled and centred coefficients for morpholin-2-one formation.
The results of the 2nd DoE (Graph 3) show that solvent type is again an important factor, with DMSO superior to
sulfolane. The loading of TsOH is also a factor, with a greater loading resulting in a higher yield. Isocyanide
loading again had no effect within the levels studied. When the loading of TsOH was increased to 1.1
equivalents, reasonable yields of morpholinones 5a-5c could be obtained (Scheme 6).
Scheme 6.
1.4. Mechanistic Studies
Scheme 3 shows two feasible, alternative mechanisms for the reaction between an N-alkyloxazolidine, an
isocyanide and a carboxylic acid to give the 4-CR product 4. To clarify the mechanism, 18O-labelled acetic acid
was used as the acid component in an MCR with oxazolidinone 1a and tert-butyl isocyanide to give 4p-18O2
(Scheme 7).
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Scheme 7
The position of the labelled oxygen atoms in the product of this reaction will be different depending on the
mechanistic pathway followed (Scheme 8). Both carbonyl oxygens in the product will be labelled if path A is
followed – (attack of the acylium ion by the carboxylic acid anion followed by O-acyl migration), while both
oxygen atoms in the ester group will be labelled via path B (acid catalysed ring opening by nucleophilic attack at
the sp3 carbon). Careful comparison of the mass spectrum of the product from the labelling experiment with the
unlabelled product 4p strongly suggested that product 4p-18O2 contains 18O labels at the two carbonyl oxygens,
as evidenced by the mass observed for the fragment 19. This indicates that carboxylic acids react via route A –
trapping the acylium ion with subsequent O-acyl migration, which may occur in either the intra- or inter-
molecular mode.
Scheme 8
The cyclic intermediate 20 could be isolated in 73% yield when 2,6-dimethylphenyl isocyanide was reacted with
1b in the absence of a carboxylic acid (Scheme 9). It is thought that the electronic stabilisation provided by the
aryl group, together with the increased steric hindrance due to the presence of the methyl groups results in a
higher stability. Heterocycle 20 was stable in air for more than three months at room temperature but could be
converted into product 4i by heating with propionic acid in the presence of TsOH in i-PrOH.
Scheme 9
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1.5. Use of Oxazolidines Derived from Ethanolamine.
Initial attempts during the early stages of our research to use oxazolidine (21a)13 in the 3-CR with MeCN as
solvent resulted in a complex mixture of products. However, Ugi reactions using unprotected ethanolamine have
been reported to occur in high yield in MeOH at room temperature in the absence of an acid catalyst.14 After
optimization of our reaction conditions using DoE, we decided to reinvestigate the reaction of oxazolidine 21a,
expecting to see the formation of Ugi product 23 as previously reported (Scheme 10).14 We were therefore
extremely surprised to obtain moderate yields of the O-acyl migration product 22a, with no detectable quantity
of the Ugi product 23 (Scheme 10). This is somewhat unexpected, as acyl transfer to the amino group in the
intermediate would be expected to be much faster than acyl transfer to the hydroxyl group due to the greater
nucleophilicity of nitrogen and the more favourable 5-exo-trig transition state (as opposed to 7-exo-trig
arrangement required for the O-acyl transfer). Interestingly, when the same reaction was carried out in methanol
at room temperature, only the Ugi product 23 was obtained. A series of experiments were carried out to
investigate the effect of temperature, solvent type and concentration on the yields of the two possible products of
this reaction. By varying the solvent and/or temperature mixtures of the two products could be obtained. The
TsOH catalyst is unnecessary for either reaction, in fact resulting in slightly lower yields.
Scheme 10
Table 7. Three-component reactions of oxazolidine 21a
Temp
(oC)
Solvent Conc.
(M)
Time
(h)
TsOH
(mmol)
22a
(%)
23
(%)
82 iPrOH 1 18 2 57 -
25 MeOH 0.4 42 2 - 81
82 iPrOH 1 18 0 70 -
25 MeOH 0.4 42 0 - 90
82 MeCN 1 18 2 - -
78 EtOH 1 18 0 30 32
65 MeOH 0.4 18 0 - 80
45 MeOH 0.4 18 0 - 84
25 EtOH 1 42 0 - 71
25 iPrOH 1 42 0 - 66
25 iPrOH 0.4 42 0 - 60
In general lower temperatures and the use of more polar solvents favoured the Ugi product 23, whereas heating
in less polar alcohols led to a preference for the O-acyl migration product 22a. Our initial hypothesis was that the
ester product 22a was formed by acyl transfer from nitrogen to oxygen when the reaction was heated. However,
on heating Ugi product 23 to reflux for 18 h in the presence of 10% TsOH only trace amounts of the ester 22a
were observed. No conversion was observed at all in the absence of the acid catalyst suggesting that the ester
22a cannot be derived from amide 23 in the multicomponent reaction. A possible explanation is that the nitrogen
atom is able to act as a general base for the OH in refluxing iPrOH, but this process is disfavoured by hydrogen
bonding to the solvent in MeOH. Moderate to good yields of the esters 22a-22d could be obtained from the
ethanolamine derived oxazolidines 21a and 21b (Scheme 11 and Table 8).13
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Table 8. Three-component reactions of ethanolamine derived oxazolidines, isoyanides and carboxylic acids.
Oxazolidinone R3 R4 Yield Product
21a tBu Ph 90% 22a
21b tBu 2-(3-indole)-
ethyl
38% 22b
21b cC6H11 Ph 37% 22c
21b tBu Ph 37% 22d
1.6. Alternative Nucleophiles for the Oxazolidine 3-CR
Thioacids have been previously employed in isocyanide based multicomponent reactions as alternatives to
carboxylic acids.15 We were keen to examine their use in an oxazolidine MCR to determine whether the softer
nature of the thioacid might favour the alternative ring-opening pathway (Path B, Scheme 3).10 Pleasingly, when
thiobenzoic acid was employed in a 3-CR with oxazolidine 1a and tert-butyl isocyanide, product 24 was
obtained in 20% yield, in which the intermediate 8 has undergone an SN2 ring opening reaction (Scheme 12).
Scheme 12
This result led us to investigate other soft nucleophiles as potential components for the oxazolidine IMCR
(Scheme 12 and Table 9). Gratifyingly, multicomponent products could also be obtained successfully with
thiophenol and 5-phenyltetrazole. In the latter case, only a single regioisomer (assigned as 26 on the basis of Noe
experiments) of the tetrazole product was obtained. We are currently investigating the scope of this variation of
our 3-CR as the incorporation of aromatic heterocycles as components in an MCR could be of great potential
utility in pharmaceutical library synthesis. The role of the cyclic intermediate 8 as a trap for a diverse range of
nucleophiles, circumvents one of the major limitations of Ugi-type reactions: the requirement for the formation
of a stable -adduct after nucleophilic attack on the acylium ion. Potentially, almost any nucleophile could be
incorporated into the reaction, through suitable choice of conditions, as the ring-opening process is likely to be
thermodynamically favourable due to formation of the stable amide bond. This novel reaction pathway is
complementary to both the Mumm rearrangement in the Ugi reaction and the Smiles rearrangement in recently
reported IMCRs of phenols and related derivatives.16
Table 9. Three-component reactions of oxazolidines, isocyanides and nucleophiles.
R1 R2 R3 Nu Yield Product
4-MeC6H4 H Me PhCSOH 20% 24
nC6H13 H Me PhSH 59% 25a
(CH2)5 Me PhSH 29% 25b
4-MeC6H4 H H PhSH 6% 25c
nC6H13 H Me 5-phenyl-1H-
tetrazole
71% 26aa
4-MeC6H4 H Me 5-phenyl-1H-
tetrazole
67% 26ba
a The product was assigned as the 1,4 substituted tetrazole isomer.
1.7. Extension to other N,O acetals
We briefly examined the extension of these novel multicomponent reactions to N,O-acetals 27 and 28 (Scheme
13).17 Pleasingly, the three-component reactions between these systems, tert-butyl isocyanide and 5-phenyl-1H-
tetrazole led to the formation of the expected multicomponent products 29 and 30 in good yield. These reactions
presumably proceed via ring-opening of the intermediates 31 and 32 respectively.
NO R3 tBu N C t-Bu
N
H
N
Nu
O R3
R1 R2 R1 R2
Nu H
Nu = S
Ph N
N N
N Ph
S
O
Ph
24 25a-25c 26a-26b
TsOH
MeCN1a, 1b,
1f, 22a
13
NO
O N
O
N CtBu
N CtBu
O
N
O
N O
N
tBu
NtBu
O
N
NHtBu
N
NN
N
Ph
NH
NN
N
Ph
NH
NN
N
Ph
N
O
O
NH
tBu
N
NN
NPh
29
27
28
30
31 32
74%
83%
TsOH, MeCN
TsOH, MeCN
Scheme 13
Similar reactions could also be carried out via 4-component condensation of benzylamine, 4-hydroxybut-2-one
33, tert-butyl isocyanide and either thiophenol or 5-phenyl-1H-tetrazole to give the products 34 and 35 (Scheme
14). These reactions are likely to involve the formation of intermediate 36, generated by trapping of an in situ
formed iminium ion with the isocyanide.
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2. Conclusions.
In summary, oxazolidines clearly constitute a powerful and flexible scaffold for a diverse set of multicomponent
transformations, leading to potentially useful structural diversity in a single reaction step. A wide range of
ethanolamines, carbonyl compounds, isocyanides and carboxylic acids can be employed in either three- or four-
component reaction sequences. These reactions can be extended to incorporate a variety of nucleophiles in place
of the carboxylic acid component including thiols and tetrazoles, and the use of other N,O-acetals is also
feasible. Further work is underway to explore the full scope of these novel multicomponent reactions of N,O-
acetals and to extend them to other systems.
3. Experimental.
3.1. General methods.
Melting points were performed on a Reichert Thermovar hot stage apparatus and are uncorrected. Boiling points
were measured during distillation. 1H NMR spectra were recorded at 300 MHz on a Bruker AMX300
spectrometer at 300K and 13C NMR spectra were recorded at 75 MHz on a Bruker AMX300 spectrometer at
300K unless otherwise stated. Macherey-Nagel 0.20mm silica gel 60 UV254 plates were used for TLC. Infrared
spectra were carried out on a Shimadzu FTIR 8700 and were recorded as a thin film or a nujol mull in between
NaCl disks. Mass spectra and accurate mass measurements were recorded using a Micromass 70-SE magnetic
sector spectrometer at the University College London Chemistry department. Unless stated, chemicals were
used as purchased and without further purification. Unless otherwise stated, all reactions were performed under
an atmosphere of nitrogen using oven dried glassware, which was cooled under a flow of nitrogen prior to use.
DMSO was distilled from calcium hydride. Benzene was distilled from sodium benzophenone ketyl. THF,
CH2Cl2, Et2O, MeCN, toluene and n-hexane, were prepared as anhydrous, degassed solvents from an anhydrous
engineering zeolite drying apparatus. Methanol from was distilled from magnesium methoxide. Anhydrous
isopropanol was purchased from Sigma Aldrich. Petrol refers to light petroleum ether bp 40-60 °C.
Oxazolidines 1a-1g and 21a-21b were prepared from the corresponding carbonyl compounds and the appropriate
aminoalcohol by: i. repeated concentration of an ethanol solution; ii. heating under Dean-Stark conditions in the
presence of a trace amount of iodine; or iii. stirring in ether in the presence of MgSO4.6, 9, 13 N,O-Acetals 28 and
14
29 were prepared from 1,2-dihydrofuran and 1,2-dihydropyran respectively according to a literature procedure.17
Spectroscopic data for these compounds were identical to those previously reported.
3.1.1. General Procedure for 3-CR in MeCN (Method A)
Oxazolidine (2 mmol), carboxylic acid (2 mmol), para-toluenesulfonic acid (38 mg, 0.2 mmol) and isocyanide
(2 mmol) were added to MeCN (5 mL) and heated at reflux under an atmosphere of nitrogen for 18-24 h until
completion by TLC. Excess solvent was removed under reduced pressure and the crude product was purified by
column chromatography to yield the product.
3.1.2. Optimized general procedure for 3-CR in iPrOH (Method B)
Oxazolidine (2 mmol), carboxylic acid (2 mmol), para-toluenesulfonic acid (8 mg, 0.04 mmol) and isocyanide
(2 mmol) were added to iPrOH (2 mL) and heated at reflux under an atmosphere of nitrogen for 18-24 h until
completion by TLC. Excess solvent was removed under reduced pressure and the crude product was purified by
column chromatography to yield the product.
3.1.3. Optimized general procedure for 4-CR in iPrOH (Method C)
Aldehyde / ketone (2 mmol), aminoalcohol (2 mmol), para-toluenesulfonic acid (8 mg, 0.04 mmol), carboxylic
acid (2 mmol), and isocyanide (2 mmol) were added to iPrOH (2 mL) and heated at reflux under an atmosphere
of nitrogen for 18-24 h. Excess solvent was removed under reduced pressure and the crude product was purified
by column chromatography to yield the product.
3.1.4. 2-[(tert-Butylcarbamoyl-p-tolylmethyl)methylamino]ethyl benzoate 4a.
Yield: 66% (Method A), 68% (Method C); Colourless oil; Rf=0.23 (Petrol:EtOAc, 2:1) IR (film) max 3400-
3100 (br), 2928, 1718, 1665, 1604, 1514, 1365 cm-1. 1H NMR (CDCl3, 300 MHz)  1.27 (9H, s, t-Bu), 2.27 (3H,
s, tolyl-CH3), 2.34 (3H, s, N-CH3), 2.67-2.88 (2H, m, N-CH2), 4.00 (1H, s, CH), 4.33-4.65 (2H, m, CH2-O), 6.93
(1H, bs, NH), 7.05-7.60 (9H, m, Ar); 13C NMR (75MHz, CDCl3)  21.1, 28.6, 40.5, 50.7, 53.5, 62.4, 75.6,
128.4, 129.0, 129.2, 129.7, 130.1, 132.9, 133.1, 137.8, 166.5, 170.8; HRMS (CI): [M+H]+, C23H31N2O3 requires
383.23347, found 383.23425.
3.1.5. 2-[(tert-Butylcarbamoyl-p-tolylmethyl)methylamino]ethyl propionate 4b.
Yield: 64% (Method A); Colourless oil; Rf 0.26 (Petrol:EtOAc, 2:1); IR (film) max 3404 (br), 3054, 2970, 2926,
2826, 1737, 1664, 1513, 1456 cm-1; 1H NMR (CDCl3, 400 MHz) 1.08 (3H, t, J 7.7Hz, CH2-CH3), 1.28 (9H, s,
t-Bu), 2.14 (3H, s, Ph-CH3), 2.25 (3H, s, N-CH3), 2.27 (2H, q, J 7.7Hz, CH2-CH3), 2.54 (2H, t, J 5.8 Hz, N-CH2),
3.76 (1H, s, CH), 4.10 (2H, t, J 5.8 Hz, O-CH2), 6.23 (1H, bs, NH), 7.03-7.10 (4H, m, Ar-H); 13C NMR (100
MHz, CDCl3)  9.5, 21.5, 28.0, 40.7, 51.0, 53.9, 62.3, 76.3, 129.2, 129.5, 133.6, 138.1, 171.2, 174.7; HRMS:
[M+H]+, C19H31N2O3 requires 335.23346, found 335.23240.
3.1.6. 2-[(Cyclohexylcarbamoyl-p-tolylmethyl)methylamino]ethyl benzoate 4c.
Yield: 71% (Method A); Pale yellow oil; Rf 0.14 (Petrol:EtOAc, 2:1); IR (film) max 3310 (br), 2922, 2952,
1726, 1651, 1562, 1460cm-1; 1H NMR (CDCl3, 300 MHz)  0.95-1.81 (10H, m, cyclohexyl), 2.27 (3H, s, Ar-
CH3), 2.29 (3H, s, N-CH3), 2.67-2.81 (2H, m, N-CH2), 3.60-3.78 (1H, m, CHNHCO), 4.00 (1H, s, CH), 4.30-
4.43 (2H, m, CH2-O), 6.93 (1H, bs, NH), 7.03-7.54 (7H, m, Ar), 8.00-8.05 (2H, m, Ar); 13C NMR (75 MHz,
CDCl3)  21.1, 24.8, 25.4, 32.7, 40.5, 50.7, 53.5, 62.3, 75.6, 128.4, 129.0, 129.2, 129.7, 130.1, 132.9, 133.1,
137.8, 166.5, 170.8; HRMS: [M+Na]+, C25H32N2NaO3 requires 431.23105, found 431.23051.
3.1.7. 2-[(Isopropylcarbamoyl-p-tolylmethyl)methylamino]ethyl benzoate 4d.
Yield: 73% (Method A); Colourless Oil; Rf 0.25 (Petrol:EtOAc, 2:1); IR (film) max 3420 (br), 2985, 2968,
1739, 1651, 1506, 1452 cm-1; 1H NMR (CDCl3, 400 MHz)  1.00 (3H, d, J 6.6 Hz, CH-CH3), 1.07 (3H, d, J
6.6Hz, CH-CH3), 2.28 (3H, s, N-CH3 or Ph-CH3), 2.29 (3H, s, N-CH3 or Ph-CH3), 2.63-2.70 (1H, m, N-CHH),
2.72-2.80 (1H, m, N-CHH), 3.96 (1H, s, C=OCH), 3.99-4.05 (1H, m, CH-(CH3)2), 4.35-4.41 (1H, m O-CHH),
4.46-4.52 (1H, m, O-CHH), 6.91 (1H, d, J 8.3 Hz, NH), 7.10 (2H, d, J 7.6 Hz, Ar-H), 7.16-7.20 (2H, m, Ar-H),
7.39-7.48 (2H, m, Ar-H), 7.56-7.62 (1H, m, Ar-H), 8.04-8.09 (2H, m, Ar-H); 13C NMR (100 MHz, CDCl3) 
21.0, 22.4, 40.4, 40.7, 53.4, 62.2, 62.3, 75.1, 128.3, 128.8, 129.1, 129.5, 130.0, 132.9, 133.0, 137.7, 166.4, 170.5;
HRMS: [M+H]+, C22H29N2O3 requires 369.2178, found 369.2177.
3.1.8. 2-[(tert-Butylcarbamoylheptyl)methylamino]ethyl benzoate 4e.
Yield: 80% (Method A), 56% (Method C); Colourless oil; Rf 0.34 (Petrol:EtOAc, 2:1); IR (film) max 3365 (br),
3026, 2948, 2926, 2856, 1724, 1674, 1506, 1452 cm-1; 1H NMR (CDCl3, 300 MHz)  0.74 (3H, t, J 6.9 Hz,
CH3), 1.16 (9H, s, tBu), 1.17-1.41 (6H, m, CH2) 1.44-1.59 (2H, m, CH2), 1.62-1.77 (2H, m, CH2), 2.23 (3H, s, N-
CH3), 2.77-2.87 (3H, m, N-CH2 & CH), 4.32-4.47 (2H, m, CH2-O), 6.62 (1H, bs, NH), 7.26-7.96 (5H, m, Ph);
13C NMR (75 MHz, CDCl3)  14.0, 22.5, 27.2, 27.4, 28.6, 29.5, 31.6, 38.3, 50.2, 53.7, 62.7, 68.9, 128.3, 129.5,
130.0, 133.0, 166.4, 172.2; HRMS: [M+H]+, C22H37N2O3 requires 377.28040, found 377.28061.
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3.1.9. 2-[(tert-Butylcarbamoylheptyl)methylamino]ethyl propionate 4f.
Yield: 78% (Method A); Colourless oil; Rf 0.21 (Petrol:EtOAc, 2:1); IR (film) max 3330 (br), 2951, 2930, 2958,
1746, 1662, 1510, 1456 cm-1. 1H NMR (CDCl3, 300 MHz)  0.77 (3H, t, J 6.6Hz, CH3), 1.05 (3H, t, J 7.5Hz,
propyl-CH3), 1.13-1.23 (6H, m, CH2), 1.25 (9H, s, tBu), 1.39-1.54 (2H, m, CH2), 1.60-1.72 (2H, m, CH2), 2.19
(3H, s, N-CH3), 2.25 (2H, q, J 7.5 Hz, C=O-CH2), 2.53-2.71 (2H, m, N-CH2), 2.77 (1H, dd, J 7.3 Hz, 5.3 Hz,
CH), 4.04 (2H, t, J 6.5 Hz, O-CH2), 6.78 (1H, bs, NH); 13C NMR (75 MHz, CDCl3)  9.0, 14.0, 22.7, 27.3,
27.5, 28.7, 29.2, 30.0, 38.4, 51.0, 53.3, 62.0, 68.9, 172.3, 174.3; HRMS: [M+H]+, C18H37N2O3 requires
329.28040, found 329.28191.
3.1.10. 2-[(1-Cyclohexylcarbamoylheptyl)methylamino]ethyl benzoate 4g.
Yield: 48% (Method A), 43% (Method C); Colourless oil; Rf 0.26 (Petrol:EtOAc, 2:1); IR (film) max 3400-
3250 (br), 2930, 2955, 1717, 1647, 1510, 1452 cm-1; 1H NMR (CDCl3, 300 MHz):  0.86 (3H, t, J 7.0 Hz,
CH3), 0.88-1.05 (3H, m, alkyl), 1.20 (9H, m, alkyl), 1.32-1.80 (8H, m, alkyl), 2.27 (3H, s, N-CH3), 2.83-2.97
(3H, m, N-CH2 and CH), 3.53-3.61 (1H, m, CH), 4.28-4.42 (2H, m, CH2-O), 6.82 (1H, d, J = 8.5 Hz, NH), 7.36-
7.41 (2H, m, Ar-H), 7.47-7.51 (1H, m, Ar-H) 7.96-8.01 (2H, m, Ar-H); 13C NMR (75 MHz, CDCl3)  14.0,
22.6, 24.8, 25.4, 27.3, 27.5, 29.5, 31.7, 32.8, 33.1, 38.4, 47.5, 53.8, 62.6, 68.5, 128.4, 129.6, 130.1, 133.1, 166.5,
171.9; HRMS: [M+H]+, C24H39N2O3 requires 403.29605, found 403.29553.
3.1.11. 3-(1H-Indol-3-yl)-2-[(1-tert-butylcarbamoylheptyl)methylaminoethyl propionate 4h.
Yield: 44% (Method A); Colourless oil; Rf 0.12 (Petrol:EtOAc, 2:1); IR (film) max 3300 (br), 3387 (br), 3020,
2959, 2930, 2858, 1732, 1666, 1514, 1456 cm-1; 1H NMR (CDCl3, 300 MHz)  0.89 (3H, t, J 6.8 Hz CH3), 1.20-
1.32 (8H, m, CH2), 1.37 (9H, s, t-Bu), 1.50-1.64 (1H, m, CHH-alkyl), 1.68-1.82 (1H, m, CHH-alkyl), 2.26 (3H,
s, N-CH3), 2.62-2.72 (2H, m, N-CH2), 2.75 (2H, t, J 7.5Hz, CO-CH2), 2.87 (1H, t, J 5.4 Hz, CH), 3.13 (2H, t, J
7.5 Hz, C=C-CH2), 4.17 (2H, t, J 5.6 Hz, O-CH2), 6.92 (1H, s, NH), 6.97 (1H, s, C=CH), 7.11 (1H, t, J 7.2 Hz,
Ar), 7.18 (1H, t, J 7.1 Hz, Ar), 7.34 (1H, d, J 7.8 Hz, Ar), 7.69 (1H, d, J 7.7 Hz, Ar), 8.84 (1H, bs, NH indole);
13C NMR (75 MHz, CDCl3)  14.1, 20.8, 22.7, 27.3, 27.6, 28.8, 29.6, 31.7, 35.1, 38.5, 50.5, 53.4, 62.3, 69.1,
111.4, 114.3, 118.5, 119.1, 121.76, 121.82, 127.1, 136.5, 172.6, 173.5; HRMS: [M+H]+, C26H41N3O3 requires
443.31479, found 443.31388.
3.1.12. 3-{[1-(2,6-Dimethylphenylcarbamoyl)heptyl]methylamino}ethyl propionate 4i.
Yield: 42% (Method A); Colourless oil; Rf 0.40 (Petrol:EtOAc, 2:1); IR (film) max 3300 (br), 3020, 2955, 2928,
2856, 1738, 1674, 1468 cm-1; 1H NMR (CDCl3, 300 MHz)  0.88 (3H, t, J 6.6 Hz, CH3), 1.02 (3H, t, J 7.5 Hz,
COCH2CH3), 1.25-1.58 (10H, m, CH2), 1.63-1.78 (1H, m, CH2), 1.88-2.00 (1H, m, CH2), 2.21 (6H, s, Ar-CH3),
2.45 (3H, s, N-CH3), 2.91 (2H, m, N-CH2, ), 3.25 (1H, t, J 6.5 Hz, CH), 4.22 (2H, t, J 5.5 Hz, CH2-O), 7.01 (3H,
s, Ar), 8.65 (1H, bs, NH). 13C NMR (75 MHz, CDCl3)  8.9, 14.1, 18.7, 22.6, 27.33, 27.38, 29.6, 31.7, 38.8,
54.0, 62.1, 68.6, 126.8, 128.8, 134.1, 134.9, 171.4, 174.4; HRMS: [M+Na]+, C22H36N2NaO3 requires 399.26235,
found 399.26169.
3.1.13. 2-{[1-(2-Chloro-6-methylphenylcarbamoyl)heptyl]methylamino}ethyl benzoate 4j.
Yield: 29% (Method A); Colourless Oil; Rf 0.18 (Petrol:EtOAc, 2:1); IR (film) max 3280 (br), 2961, 2919,
2874, 1719, 1637, 1467 cm-1; 1H NMR (CDCl3, 400 MHz)  0.77 (3H, t, J 6.9 Hz, CH2CH3), 1.16-1.28 (6H, m,
CH2), 1.32-1.47 (2H, m, CH2), 1.65-1.75 (1H, CH2), 1.87-1.94 (1H, m, CH2), 2.10 (3H, s, N-CH3), 2.55 (3H, s,
Ph-CH3), 3.13 (2H, t, J 5.6 Hz, N-CH2), 3.53 (1H, dd, J 7.1, 6.0 Hz, CH), 4.45-4.90 (2H, t, J 5.6 Hz, O-CH2),
7.05-7.32 (2H, m, Ar), 7.44-7.49 (2H, m, Ar-H), 7.57-7.61 (1H, m, Ar), 7.95-8.00 (1H, m, Ar-H), 8.11 (2H, m,
Ar-H), 8.70 (1H, bs, NH); 13C NMR (100 MHz, CDCl3)  13.9, 18.9, 22.5, 27.2, 27.5, 29.3, 31.5, 38.4, 53.6,
62.0, 68.3, 127.0, 127.5, 128.17, 128.23, 129.0, 129.4, 130.0, 132.9, 133.2, 137.6, 166.4, 171.3; HRMS:
[M+H]+, C25H34ClN2O3 requires 445.2258, found 445.2266.
3.1.14. 2-{[tert-Butylcarbamoyl-(4-methoxyphenyl)methyl]methylamino}ethyl benzoate 4k.
Yield: 68% (Method A), 66% (Method C); Colourless oil; Rf 0.40 (Petrol:EtOAc, 2:1); IR (film) max 3390 (br),
2980, 2970, 2930, 2885, 1716, 1678, 1510, 1452 cm-1; 1H NMR (CDCl3, 300 MHz)  1.27 (9H, s, t-Bu), 2.33
(3H, s, N-CH3), 2.67-2.85 (2H, m, N-CH2), 4.02 (3H, s, OMe), 4.06 (1H, s, CH), 4.32-4.62 (2H, m, CH2-O), 6.78
(2H, d, J 6.8 Hz, m-PhOMe), 7.04 (1H, bs, NH), 7.17 (2H, d, J 6.8 Hz, Ar-H), 7.32-7.53 (3H, m, Ar-H), 8.00
(2H, d, J 8.5 Hz, Ar-H); 13C NMR (75 MHz, CDCl3)  28.5, 40.4, 50.6, 53.4, 55.2, 62.3, 75.1, 113.8, 128.1,
128.4, 129.6, 130.1, 130.2, 132.5, 133.1, 159.4, 166.4, 170.9; HRMS: [M+H]+, C23H31N2O4 requires 399.22837,
found 399.22720.
3.1.15. 2-{[tert-Butylcarbamoyl-4-nitrophenyl)methyl]methylamino}ethyl benzoate 4l.
Yield: 47% (Method A), 30% (Method C); Orange Oil; Rf 0.40 (Petrol:EtOAc, 2:1); IR (film) max 3300 (br),
3060, 2990, 2895, 2805, 1716, 1682, 1521, 1452 cm-1; 1H NMR (CDCl3, 300 MHz)  1.26 (9H, s, t-Bu), 2.30
(3H, s, N-CH3), 2.67-2.88 (2H, t, J 5.6 Hz N-CH2), 4.18 (1H, s, CH), 4.41(2H, m, CH2-O), 6.98 (1H, bs, NH),
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7.39-7.47 (4H, m, Ar-H), 7.52-7.57 (1H, m, Ar-H), 8.01 (2H, d, J 8.6 Hz, Ar-H), 8.12 (2H, d, J 8.6 Hz, Ar-H);
13C NMR (75 MHz, CDCl3)  28.5, 40.0, 51.0, 53.8, 61.9, 74.7, 123.5, 128.5, 129.6, 129.9, 130.2, 133.3, 143.0,
147.5, 166.4, 169.1; HRMS: [M+Na]+, C22H27N3NaO5 requires 437.19099, found 437.19266.
3.1.16. 2-[Benzyl-(tert-butylcarbamoyl-p-tolylmethyl)amino]ethyl benzoate 4m.
Yield: 44% (Method A); Colorless Oil; Rf 0.28 (Petrol:EtOAc, 4:1); IR (film) max 3342 (br), 2924, 1717, 1678,
1510, 1364 cm-1; 1H NMR (CDCl3, 300 MHz) 1.26 (9H, s, t-Bu), 2.34 (3H, s, Ph-CH3), 2.79-2.98 (2H, m, N-
CH2), 3.53-3.58 (1H, d, J 4.7 Hz, Ph-CH2), 3.87-3.92 (1H, d, J = 4.7 Hz, benzylic CH2), 4.20-4.49 (2H, m, CH2-
O), 4.39 (1H, s, CH), 6.96 (1H, bs, NH), 7.13-7.98 (14H, m, Ar-H); 13C NMR (75 MHz, CDCl3)  21.2, 28.7,
49.2, 50.9, 56.3, 62.6, 70.2, 127.4, 128.4, 128.5, 129.0, 129.7, 129.9, 130.2, 132.1, 133.1, 137.6, 138.8, 166.5,
170.8; HRMS: [M+H]+, C29H35N2O3 requires 459.26475, found 459.26337.
3.1.17. 2-[(1-tert-Butylcarbamoylcyclohexyl)methylamino]ethyl benzoate 4n.
Yield: 63% (Method A); Colourless Oil; Rf 0.63 (Petrol:EtOAc, 2:1); IR (film) max 3380 (br), 2973, 2944,
2870, 1710, 1680, 1505, 1465 cm-1; 1H NMR (CDCl3, 300 MHz)  1.19 (9H, s, t-Bu), 1.30-1.37 (2H, m, CH2)
1.51-1.91 (8H, m, CH2), 2.21 (3H, s, N-CH3), 2.68 (2H, t, J 6.0 Hz, N-CH2, ), 4.28 (2H, t, J 6.1 Hz CH2-O), 6.22
(1H, bs, NH), 7.04-7.41 (3H, m, Ar), 7.92 (2H, d, J 9.4 Hz, Ar); 13C NMR (75 MHz, CDCl3)  22.9, 25.9, 28.6,
30.2, 36.0, 49.8, 50.1, 63.7, 66.4, 128.3, 129.9, 130.1, 132.9, 166.3, 174.4; HRMS: [M+H]+, C21H33N2O3
requires 361.24910, found 361.24790.
3.1.18. 2-[tert-Butyl-(tert-butylcarbamoyl-p-tolyl-methyl)amino]ethyl acetate 4o.
Yield: 20% (Method A); Colourless needles mp 90-91 °C (CHCl3); Rf 0.40 (Petrol:EtOAc, 2:1); IR (KBr Disc)
max 3314 (br), 2968, 2924, 1738, 1670, 1506, 1456 cm-1;  1H NMR (CDCl3, 300 MHz)  1.16 (9H, s, t-Bu),
1.41 (9H, s, tBu), 2.00 (3H, s, CO2CH3), 2.28 (3H, s, CH3 tolyl), 2.30-2.41 (1H, m, N-CHH), 2.81-2.92 (1H, m,
N-CHH), 3.58-3.67 (1H, m, O-CHH), 3.78-3.87 (1H, m, O-CHH), 4.55 (1H, s, CH), 7.01 (2H, d, J 8.1 Hz, Ph),
7.08 (2H, d, J 8.1 Hz, Ph), 7.83 (1H, bs, NH); 13C NMR (75 MHz, CDCl3)  21.1, 27.9, 28.7, 42.8, 50.6, 56.7,
65.2, 66.6, 129.5, 130.2, 134.4, 137.3, 170.7, 174.0; HRMS: [M+H]+, C21H35N2O3 requires 363.26475, found
363.26552.
3.1.19. 2-[(tert-Butylcarbamoyl-p-tolylmethyl)methylamino]ethyl acetate 4p.
Yield: 54% (Method B); Colourless Oil; Rf 0.40 (2:1 Petrol:EtOAc); IR (thin film) max 3330 (br), 2987, 2943,
2872, 2875, 1732, 1667, 1515, 1455 cm-1; 1H NMR (CDCl3, 400 MHz)  1.28 (9H, s, t-Bu), 2.09 (3H, s,
COCH3), 2.16 (3H, s, tolyl-CH3), 2.23 (3H, s, N-CH3), 2.54 (2H, t, J 5.6 Hz, N-CH2), 3.76 (1H, s, CH), 4.09
(2H, t, J 5.6, O-CH2), 6.95 (1H, bs, NH), 7.11 (2H, d, J 8.0 Hz, Ar), 7.23 (2H, d, J 8.0 Hz, Ar); 13C NMR
(CDCl3, 100 MHz)  21.1, 21.2, 28.7, 40.2, 51.5, 53.5, 61.9, 75.5, 127.5, 128.8, 129.1, 133.0, 138.8, 167.4,
169.2; HRMS: [M+H]+, C18H29N2O3 requires 321.2173, found 321.2155; LRMS: [M+H]+, 176 (100), 321 (78,
M+H), 220 (54), 343 (17, M+Na), 177 (12), 221 (8).
3.1.20. 2-[(tert-Butylcarbamoyl-p-tolylmethyl)methylamino]ethyl acetate-18O2 4p-18O2.
Yield: 47% (Method B); Colourless Oil; Rf 0.37 (Petrol:EtOAc, 2:1); IR (film) max 3360 (br), 2966, 2920,
2884, 1708, 1643, 1512, 1456 cm-1; 1H NMR (CDCl3, 300 MHz)  1.28 (9H, s, t-Bu), 2.00 (3H, s, COCH3),
2.15 (3H, s, tolyl-CH3), 2.24 (3H, s, N-CH3), 2.57-2.62 (2H, m, N-CH2), 3.83 (1H, s, CH), 4.10 (2H, t, J 5.7 Hz,
O-CH2), 6.99 (1H, bs, NH), 7.04-7.23(4H, m, Ar-H); 13C NMR (75 MHz, CDCl3)  20.9, 21.0, 28.5, 40.0, 50.6,
53.3, 61.6, 75.5, 128.6, 128.8, 129.0, 129.2, 137.7, 137.9, 170.3 (br), 170.7; HRMS: [M+H]+, C18H29N2O18O2
requires 325.22630, found 325.22528.
Fragmentation of the [M+H]+ ion, m/z 321 was achieved by in-source collision induced dissociation (CID). The
in-source CID mass spectrum for the labelled compound 4p-18O2 showed the fragment ion at m/z 222, consistent
with [M+H – C4H9NHC18OH]+, a loss of 103 Da. The in-source CID mass spectrum for the non-labeled
compound 4p showed the fragment ion at m/z 220, consistent with [M+H – C4H9NHCOH]+, a loss of 101 Da.
3.2. Multicomponent Reaction of Acid-Aldehydes
3.2.1. 5-Methyl-1-oxo-3,4,5,6-tetrahydro-1H-benzo[f][1,4]oxazocine-6-carboxylic acid cyclohexylamide 12.
2-(Methylamino)-ethanol (161 l, 2 mmol), TsOH (8 mg, 0.04 mmol), and cyclohexyl isocyanide (202 l, 2
mmol) were added to a solution of 2-carboxybenzaldehyde (300 mg, 2 mmol) in anhydrous iPrOH (1.5 mL).
The mixture was stirred for 48 h at rt under N2. Excess solvent was removed under reduced pressure and the
residue was purified by flash chromatography (2:1 Petrol:EtOAc) to give 12 as a white solid, which was
recrystallised from methanol to give colourless needles (202 mg, 33 %); mp 146-148oC; Rf 0.12 (2:1
Petrol:EtOAc); IR (KBr Disc) max 3309, 2936, 2854, 1717, 1634, 1539, 1454 cm-1. 1H NMR (CDCl3)  1.08-
1.37 (5H, m, cy), 1.51-1.88 (5H, m, cy), 2.32 (3H, s, N-CH3), 2.94 (1H, ddd, J 14.2, 7.3, 3.8 Hz, N-CHH), 3.07
(1H, ddd, J 14.2, 4.0, 3.8 Hz, N-CHH), 3.69 (1H, dtd, J 10.5, 8.5, 3.9 Hz, cy), 3.84 (1H, ddd, J 12.6, 5.8, 3.8 Hz,
O-CHH), 4.07 (1H, ddd, J 12.6, 7.3, 4.0 Hz, O-CHH), 4.27 (1H, s, CH), 6.96 (1H, d, J 8.2 Hz, NH), 7.04-7.06
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(1H, m, Ar), 7.28-7.32 (3H, m, Ar); 13C NMR (CDCl3)  24.6, 25.4, 32.7, 32.9, 42.4, 48.1, 55.5, 64.8, 70.6,
128.3, 128.6, 130.2, 130.8, 134.9, 168.3, 173.4; HRMS: [M+H]+, C18H25N2O3 requires 317.18652, found
317.18574; MS: (EI) 339 (100 M+Na), 317 (83, M+H), 340 (17), 318 (13), 202 (12), 221 (7).
3.2.2. 5-Benzyl-1-oxo-3,4,5,6-tetrahydro-1H-benzo[f][1,4]oxazocine-6-carboxylic acid tert-butylamide 13.
2-(Benzylamino)-ethanol (284 l, 2 mmol), TsOH (8 mg, 0.04 mmol), and tert-butyl isocyanide (226 l, 2
mmol) were added to a solution of 2-carboxybenzaldehyde (300 mg, 2 mmol) in anhydrous iPrOH (1.5 mL).
The mixture was stirred for 7 days at rt under N2. Excess solvent was removed in vacuo and the residue was
purified by flash chromatography (3:2 Petrol:EtOAc) to give 13 as a pale yellow oil (179 mg, 25 %); Rf 0.40
(1:1 Petrol:EtOAc); IR (thin film) max 3340 (br), 2984, 2924, 2885, 1716, 1667, 1486, 1408 cm-1; 1H NMR
(CDCl3)  1.29 (9H, s, t-Bu), 2.82 (1H, ddd, J 14.2, 6.2, 4.2 Hz, N-CHCH), 3.19 (1H, ddd, J 14.2, 6.7, 4.8 Hz,
N-CHH), 3.78 (2H, s, Ar-CH2), 3.88 (1H, ddd, J 12.5, 6.8, 4.2 Hz, O-CHH), 4.11 (1H, ddd, J 12.4, 6.3, 4.8 Hz,
O-CHH), 4.41 (1H, s, CH), 6.42 (1H, bs, NH), 7.29-7.42 (9H, m,Ar); 13C NMR (CDCl3)  28.5, 51.5, 51.8, 56.9,
64.9, 71.0, 127.3, 127.7, 128.4, 128.4, 128.7, 128.9, 129.1, 130.2, 130.8, 134.4, 137.5, 168.9, 173.7; HRMS (EI):
[M+H]+, C22H27N2O3 requires 367.20217, found 367.20211; LRMS (EI): 389 (100 M+Na), 367 (64, M+H), 390
(23), 369 (9), 368 (8), 181 (7).
3.2.3. 11-Methyl-7-oxo-6,7,9,10,11,12-hexahydro-5,8-dioxa-11-aza-benzocyclodecene-12-carboxylic acid
tert-butylamide 14.
2-(Methylamino)-ethanol (161 l, 2 mmol), TsOH (8 mg, 0.04 mmol), and tert-butyl isocyanide (226 l, 2
mmol) were added to a solution of 2-formylphenoxyacetic acid (360 mg, 2 mmol) in anhydrous iPrOH (1.5 mL).
The mixture was stirred for 48 h at rt. Excess solvent was removed under reduced pressure and the residue was
purified by flash chromatography (1:1 Petrol:EtOAc) to give 14 as a white solid which was recrystallised from
iPrOH to give colourless prisms (317 mg, 49 %); mp 140-143 °C; Rf 0.20 (1:1 Petrol:EtOAc); IR (KBr Disc)
max 3356, 2944, 1742, 1674, 1508, 1487, 1448 cm-1; 1H NMR (CDCl3)  1.30 (9H, s, t-Bu), 2.44 (3H, s, N-CH3),
2.53 (1H, dt, J 15.5, 2.3 Hz, N-CHH), 2.71-2.82 (1H, m, N-CHH), 4.24 (2H, dd, J 6.9, 1.7 Hz, O-CH2), 4.40
(1H, d, J 13.4 Hz, OCHHC=O), 4.58 (1H, d, J 13.4 Hz, OCHHC=O), 4.79 (1H, s, CH), 6.66 (1H, bs, NH), 6.98-
7.07 (2H, m, Ar), 7.18 (1H, td, J 7.7, 1.6 Hz, Ar), 7.26 (1H, dd, J 7.6, 1.4 Hz, Ar); 13C NMR (CDCl3)  28.6,
38.8, 50.4, 50.6, 60.6, 66.8, 72.8, 121.2, 124.5, 128.6, 129.5, 130.9, 156.8, 168.1, 171.1; HRMS (EI): [M+H]+,
C17H25N2O4 requires 321.18143, found 321.18214; LRMS (EI): 321 (100 M+H), 322 (18), 343 (10, M+Na), 220
(7), 276 (5), 298 (4).
3.3. General procedure for Morpholin-2-one synthesis
Oxazolidine (2 mmol), TsOH (419 mg, 2.2 mmol) and tert-butyl isocyanide (226 µl, 2 mmol) were added to
reagent grade DMSO (5 mL) and heated to 75 °C under an atmosphere of nitrogen for 24 hours. The reaction
was cooled to rt and sat. NaHCO3 (aq) (5 mL) and EtOAc (5 mL) were added. The organic layer was separated
and the aqueous layer was further extracted with EtOAc (2 × 5 mL). The combined organic layers were then
washed with brine (5 mL), dried (MgSO4), filtered and evaporated under reduced pressure and purified by
column chromatography (Petrol:EtOAc).
3.3.1. 3-Hexyl-4-methylmorpholin-2-one 5a.
Yield: 69%; Colourless oil; Rf 0.25 (2:1 Petrol:EtOAc); IR (thin film) max 2963, 2931, 2874, 2867, 1738, 1552
1459 cm-1; 1H NMR (CDCl3, 300 MHz)  0.83 (3H, t, J 6.8 Hz, CH2CH3), 1.23-1.32 (7H, m, alkyl), 1.45-1.54
(1H, m, alkyl), 1.70-1.78 (1H, m, alkyl), 1.88-2.02 (1H, m, alkyl), 2.30 (3H, s, N-CH3), 2.60 (1H, ddd, J 12.8,
11.1, 3.3 Hz, N-CHH), 2.84 (1H, dt, J 9.8, 2.7 Hz, N-CHH), 2.99 (1H, t, J 4.9 Hz, CH), 4.23-4.27 (1H, ddd, J
10.8, 3.2, 2.3 Hz, O-CHH), 4.38 (1H, td, J 10.9, 3.1 Hz, O-CHH); 13C NMR (CDCl3, 75 MHz)  14.0, 22.6,
24.7, 29.3, 30.1, 31.7, 43.1, 51.1, 67.0, 67.7, 170.5; HRMS: [M+H]+, C11H22NO2 requires 200.16505, found
200.16432.
3.3.2. 4-(4-Benzyl)-3-p-tolyl-morpholin-2-one 5b.
Yield: 60%; Colourless oil; Rf 0.45 (2:1 Petrol:EtOAc); IR (thin film) max 3018, 2973, 1742, 1512, 1452 cm-1;
1H NMR (CDCl3, 400 MHz)  2.27 (3H, s, Ph-CH3), 2.55 (1H, ddd, J 12.7, 11.0, 3.2 Hz, N-CHH), 2.90 (1H, dt,
J 12.7, 2.7 Hz, N-CHH), 3.08 (1H, d, J 13.3 Hz, Ph-CHH), 3.71 (1H, d, J 13.3 Hz, Ph-CHH), 4.14 (1H, s, CH),
4.27 (1H, ddd, J 10.8, 3.2, 2.4 Hz, O-CHH), 4.46 (1H, td, J 11.0, 3.2 Hz, O-CHH), 7.11 (1H, m, Ar), 7.14 (1H,
m, Ar), 7.16-7.19 (3H, m, Ar), 7.21-7.24 (2H, m, Ar), 7.36-7.39 (2H, m, Ar); 13C NMR (CDCl3, 100 MHz) 
21.5, 47.1, 59.2, 69.0, 70.7, 127.9, 128.7, 129.20, 129.23, 129.9, 134.9, 137.5, 138.6, 169.3; HRMS: [M+H]+,
C18H20NO2 requires 282.14940, found 282.14894.
3.3.3. 4-Methyl-3-p-tolylmorpholin-2-one 5c.
Yield: 55%; Colourless oil; Rf 0.10 (1:1 Petrol:EtOAc); IR (thin film) max 2951, 2795, 1738, 1514, 1456 cm-1;
1H NMR (CDCl3, 400 MHz)  2.19 (3H, s, Ar-CH3/N-CH3), 2.32 (3H, s, Ar-CH3/N-CH3), 2.79-2.84 (1H, m, N-
CHH), 3.00 (1H, ddd, J 12.7, 3.0, 1.9 Hz, N-CHH), 3.87 (1H, s, CH), 4.37-4.45 (1H, ddd, J 10.8, 3.2, 2.0 Hz, O-
CHH), 4.64 (1H, td, J 11.3 3.5 Hz, O-CHH), 7.15 (2H, d, J 8.0 Hz, Ar-H), 7.27 (2H, d, J 8.0 Hz, Ar-H); 13C
18
NMR (CDCl3, 100 MHz)  21.2, 43.6, 51.0, 68.4, 72.3, 128.7, 129.3, 134.4, 138.1, 168.9; HRMS: [M+H]+,
C12H16NO2 requires 206.11810, found 206.11854.
3.4. (Z)-(2,6-Dimethylphenyl)-(3-heptyl-4-methylmorpholin-2-ylidene)amine 20.
2-Hexyl-3-methyloxazolidine 1b (342 mg, 2 mmol), TsOH (8 mg, 0.04 mmol), and 2,6-dimethylphenyl
isocyanide (262 mg, 2 mmol) were added to anhydrous iPrOH (2 mL) and heated at reflux under an atmosphere
of nitrogen for 17 hours. Excess solvent was removed under reduced pressure and the crude product was
purified by column chromatography (10:1 Petrol:EtOAc) to yield 20 as a colourless oil (421 mg, 73 %); Rf 0.23
(6:1 Petrol:EtOAc); IR (thin film) max 3021, 2957, 2957, 2854, 1624, 1477, 1443 cm-1; 1H NMR (CDCl3, 300
MHz)  0.99 (3H, t, J 6.4 Hz, CH2CH3), 1.33-1.51 (6H, m, alkyl), 1.58-1.74 (2H, m, alkyl), 1.93-2.04 (1H, m,
alkyl), 2.17 (6H, s, Ph-(CH3)2), 2.21-2.34 (1H, m, alkyl), 2.48 (3H, s, N-CH3), 2.65 (1H, ddd, J 12.8, 9.4, 3.8 Hz,
N-CHH), 2.92 (1H, dt, J 12.8, 3.5 Hz, N-CHH), 3.32 (1H, t, J 4.8 Hz, CH), 4.05-4.22 (2H, m, O-CH2), 6.83 (1H,
t, J 7.6 Hz, Ar-H), 7.04 (2H, d, J 7.6 Hz, Ar-H); 13C NMR (CDCl3, 75 MHz)  14.2, 18.9, 22.7, 25.4, 29.7, 31.8,
32.0, 43.5, 51.1, 65.2, 66.4, 122.6, 127.5, 128.3, 145.4, 155.8; HRMS (CI): [M+H]+, C19H31N2O requires
303.24364, found 303.24371.
3.5. General procedure for reaction of N-unsubstituted oxazolidines to give 22a-22d
Oxazolidine 21 (2 mmol), benzoic acid (2 mmol) and tert-butyl isocyanide (2 mmol) were added to anhydrous
iPrOH (2 mL) and heated at reflux under an atmosphere of nitrogen for 18 h. Excess solvent was removed under
reduced pressure and the crude product was purified by column chromatography (4:1 Petrol:EtOAc) to yield the
ester 22.
3.5.1. 2-[(tert-Butylcarbamoyl-p-tolylmethyl)amino]ethyl benzoate 22a.
Yield: 90%; Rf = 0.36 (2:1 Petrol:EtOAc); Colourless oil (516 mg, 70 %). Rf 0.36 (2:1 Petrol:EtOAc); IR (thin
film) max 3370 (br), 2985, 2930, 2880, 1716, 1670, 1514, 1452 cm-1; 1H NMR (CDCl3)  1.28 (9H, s, t-Bu), 2.07
(1H, bs, NH), 2.28 (3H, s, tolyl-CH3), 2.88-3.02 (2H, m, N-CH2), 4.08 (1H, s, CH), 4.34-4.41 (2H, m, O-CH2),
6.96 (1H, s, NH), 7.10 (2H, d, J 7.8 Hz, Ar), 7.22 (2H, d, J 8.1 Hz, Ar), 7.38-7.55 (3H, m, Ar), 8.00 (2H, d, J 8.3
Hz, Ar); 13C NMR (CDCl3)  21.1, 28.7, 47.1, 50.6, 64.3, 67.7, 126.8, 128.4, 129.1, 129.5, 130.0, 133.1, 136.6,
137.7, 166.5, 171.2; HRMS (FAB): [M+H]+, C22H29N2O3 requires 369.21781, found 369.21690; LRMS
(FAB): 369 (100, M+H), 268 (61), 370 (27), 154 (23), 176 (13).
3.5.2. 2-(1-(tert-Butylamino)-2-methyl-1-oxopropan-2-ylamino)ethyl 3-(1H-indol-3-yl)propanoate 22b.
Yield: 38%; Colourless prisms, mp 112-114 °C (iPrOH); Rf 0.11 (Petrol:EtOAc/Et3N, 50:50:1); IR (KBr Disc)
max 3354, 3318, 3171, 2974, 2923, 1730, 1645, 1521, 1456 cm-1; 1H NMR (CDCl3, 300 MHz)  1.22 (6H, s,
(CH3)2), 1.27 (9H, s, t-Bu), 2.04 (1H, s, NH), 2.67 (2H, t, J 5.5 Hz, N-CH2), 2.75 (2H, t, J 7.5 Hz, CO-CH2), 3.12
(2H, t, J 7.5 Hz, Indole-CH2), 3.61-4.36 (2H, m, O-CH2), 7.00 (1H, d, J 2.2 Hz, Ar-H), 7.11-7.22 (2H, m, Ar-
H), 7.28 (1H, bs, NH amide), 7.34 (1H, d, J 8.0 Hz, Ar-H), 7.59 (1H, d, J 7.7 Hz, Ar-H), 8.51 (1H, bs, NH
indole); 13C NMR (CDCl3, 75 MHz)  20.7, 25.5, 28.7, 34.9, 42.3, 50.1, 58.8, 64.5, 111.3, 114.5, 118.6, 119.2,
121.6, 122.0, 127.1, 136.4, 173.4, 175.6; HRMS (CI): [M+H]+, C21H32N3O3 requires 374.24437, found
374.24483.
3.5.3. 2-(1-Cyclohexylcarbamoyl-1-methylethylamino)ethyl benzoate 22c.
Yield: 37%; Yellow oil; Rf 0.19 (Et2O); IR (thin film) max 3320 (br), 2930, 2871, 1720, 1661, 1514, 1463 cm-1;
1H NMR (CDCl3, 300 MHz)  0.83-1.04 (4H, m, Cy), 1.27 (6H, s, (CH3)2), 1.44-1.61 (4H, m, Cy), 1.70-1.79
(2H, m, Cy), 2.83 (2H, t, J 5.4 Hz, N-CH2), 3.56-3.64 (1H, tdt, J 10.6, 8.9, 3.9 Hz CHNHCO), 4.35 (2H, t, J 5.4
Hz, O-CH2), 7.21 (1H, bd, J 8.4 Hz, CONH), 7.41 (2H, dd, J 8.5, 7.4 Hz, Ar-H), 7.53 (1H, tt, J 7.4, 1.3 Hz, Ar-
H), 8.00 (2H, br d, J 8.5 Hz, Ar-H); 13C NMR (CDCl3, 75 MHz)  24.8, 25.5, 25.7, 33.0, 42.7, 47.5, 58.5, 64.9,
128.4, 129.6, 130.0, 133.1, 166.5, 175.2; HRMS: [M+H]+, C19H29N2O3 requires 333.21782, found 333.21810.
3.5.4. 2-(1-tert-Butylcarbamoyl-1-methylethylamino)ethyl benzoate 22d.
Yield: Colourless oil (224 mg, 37 %). Rf 0.35 (1:1 Petrol:EtOAc); IR (thin film) max 3330 (br), 2995, 2940,
2880, 1720, 1665, 1510, 1406 cm-1; 1H NMR (CDCl3)  1.27 (9H, s, t-Bu), 1.28 (6H, s, 2 × CH3), 2.86 (2H, t, J
5.5 Hz, N-CH2), 4.37 (2H, t, J 5.6 Hz, O-CH2), 7.13 (1H, bs, NH), 7.43 (2H, t, J 7.5 Hz, m-Ar), 7.52 (1H, m, p-
Ar), 8.01 (2H, d, J 7.5 Hz, o-Ar); 13C NMR (CDCl3)  25.6, 28.6, 42.6, 50.1, 58.9, 65.0, 128.4, 129.6, 130.0,
133.1, 166.6, 175.6; HRMS (CI ): [M+H]+, C17H27N2O3 requires 307.20216, found 307.20284; LRMS (CI): 206
(100), 307 (63, M+H), 111 (16), 149 (15), 113 (15), 207 (14).
3.5.5. N-(tert-Butylcarbamoyl-p-tolylmethyl)-N-(2-hydroxyethyl)benzamide 23.
2-p-Tolyl-oxazolidine 21a (327 mg, 2 mmol), benzoic acid (244 mg, 2 mmol), and tert-butyl isocyanide (226 l,
2 mmol) were added to anhydrous methanol (5 mL) at room temperature and stirred for 42 h under an
atmosphere of nitrogen. Excess solvent was removed under reduced pressure and the crude product was purified
by column chromatography (2:1 Petrol:EtOAc) to yield 23 (660 mg, 90 %) as colourless needles; Rf 0.16 (2:1
Petrol:EtOAc); mp 138-139 °C (iPrOH /Petrol); IR (KBr Disc) max 3406 (br), 3317, 3027, 2993, 2981, 2931,
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1665, 1618, 1542, 1450, 1419 cm-1; 1H NMR (DMSO-d6, 400 MHz, 373K)  1.35 (9H, s, t-Bu), 2.33 (3H, s, Ph-
CH3), 3.13-3.27 (2H, m, N-CH2), 3.39-3.49 (2H, m, O-CH2), 4.45 (1H, bs, OH), 5.58 (1H, s, CH), 7.20-7.26
(4H, m, Ar-H), 7.38 (1H, bs, NH), 7.43-7.48 (5H, m, Ar-H); 13C NMR (100MHz, DMSO-d6, 373K)  19.9,
27.9, 47.5, 50.1, 58.6, 63.9, 125.9, 127.6, 128.34, 128.40, 128.5, 132.9, 136.6, 136.7, 168.5, 171.5; HRMS:
[M+H]+, C22H29N2O3 requires 369.21782, found 369.21828.
3.6. Incorporation of Other Nucleophilic Components
3.6.1. S-{2-[(tert-Butylcarbamoyl-p-tolylmethyl)methylamino]ethyl}thiobenzoate 24.
Oxazolidine 1a (355 mg, 2 mmol), thiobenzoic acid (259 l, 2 mmol), TsOH (38 mg, 0.2mmol) and tert-butyl
isocyanide (166 mg, 226 l, 2 mmol) were added to MeCN (5 mL) and heated at reflux under an atmosphere of
argon for 24 h. Excess solvent was removed under reduced pressure and the crude product was purified by
column chromatography (4:1 Petrol:EtOAc) to yield 24 as a pale yellow oil; Rf 0.33 (Petrol:EtOAc, 2:1); IR
(thin film) max 3444 (br), 3007, 2970, 2898, 1667, 1662, 1506, 1470; 1H NMR (CDCl3, 400MHz)  1.24 (9H, s,
t-Bu), 2.15 (3H, s, N-CH3), 2.22 (3H, s, Ar-CH3), 3.02 (2H, t, J 6.7 Hz, N-CH2), 3.09-3.21 (2H, m, S-CH2), 3.81
(1H, bs, CH), 7.02 (2H, d, J 8.0 Hz, Ar-H), 7.09 (2H, d, J 8.0 Hz, Ar-H), 7.34-7.38 (2H, m, Ar-H), 7.47-7.51
(1H, m, Ar-H), 7.87-7.89 (2H, m, Ar-H); 13C NMR (100 MHz, CDCl3)  21.5, 27.6, 29.0, 39.9, 51.0, 54.5, 75.5,
127.1, 128.5, 128.9, 130.0, 132.8, 133.4, 136.8, 137.5, 170.5, 191.2; HRMS: [M+H]+, C23H31N2O2S requires
399.2106, found 399.2109.
3.6.2. 2-[Methyl-(2-phenylsulfanylethyl)amino]octanoic acid tert-butylamide 25a.
Oxazolidine 1b (342 mg, 2 mmol), thiophenol (205 l, 2 mmol), TsOH (19 mg, 0.1mmol) and tert-butyl
isocyanide (166 mg, 226 l, 2 mmol) were added to anhydrous MeCN (1 mL) and heated at reflux under an
atmosphere of nitrogen for 24 h. Excess solvent was removed under reduced pressure and the crude product was
purified by column chromatography (8:1 Petrol:EtOAc) to yield 25a as a colourless oil (428 mg, 59 %); Rf 0.21
(6:1 Petrol:EtOAc); IR (thin film) max 3430 (br), 2958, 2927, 2856, 1674, 1510, 1481, 1456 cm-1; 1H NMR
(CDCl3, 300 MHz)  0.81 (3H, t, J 6.7 Hz, CH2CH3), 1.21 (7H, bs, alkyl), 1.28 (9H, s, t-Bu), 1.34-1.59 (2H, m,
alkyl), 1.64-1.73 (1H, m, alkyl), 2.19 (3H, s, N-CH3), 2.71 (2H, t, J 6.6 Hz, N-CH2), 2.81 (1H, dd, J 5.5, 7.1 Hz,
CH), 2.99 (2H, t, J 6.6 Hz, S-CH2), 7.10-7.29 (5H, m, Ph); 13C NMR (CDCl3, 75 MHz)  14.1, 22.6, 27.2, 27.5,
28.7, 29.2, 31.7, 32.7, 37.4, 50.4, 53.7, 68.7, 126.0, 128.9, 129.2, 136.4, 172.4; HRMS: [M+H]+, C21H37N2OS
requires 365.26265, found 365.26202.
3.6.3. 1-[Methyl(2-phenylsulfanylethyl)amino]cyclohexanecarboxylic acid tert-butylamide 25b.
Oxazolidine 1f (311 mg, 2 mmol), thiophenol (205 l, 2 mmol), TsOH (19 mg, 0.1 mmol) and tert-butyl
isocyanide (166 mg, 226 l, 2 mmol) were added to anhydrous MeCN (1 mL) and heated at reflux under an
atmosphere of nitrogen for 24 h. Excess solvent was removed under reduced pressure and the crude product was
purified by column chromatography (6:1 Petrol:EtOAc) to yield 25b as a colourless oil (154 mg, 22 %); Rf 0.4
(6:1 Petrol:EtOAc); IR (thin film) max 3450 (br), 2959, 2931, 2873, 2860, 1728, 1464 cm-1; 1H NMR (CDCl3,
300 MHz)  1.32 (9H, s, t-Bu), 1.39-1.77 (10H, m, cy), 2.23 (3H, s, N-CH3), 2.70 (2H, br t, J 7.0 Hz, N-CH2),
3.03 (2H, br t, J 7.0 Hz, S-CH2), 6.71 (1H, bs, NH), 7.14-7.34 (5H, m, Ar-H); 13C NMR (CDCl3, 75 MHz) 
23.0, 26.0, 28.7, 30.3, 33.5, 34.5, 66.6, 125.9, 128.9, 129.0, 136.8, 175.6; HRMS: [M+H]+, C20H33N2OS requires
349.23135, found 349.23170.
3.6.4. N-tert-Butyl-2-(2-phenylsulfanylethylamino)-2-p-tolylacetamide 25c.
Oxazolidine 22a (163 mg, 2 mmol), thiophenol (205 l, 2 mmol), TsOH (8 mg, 0.02 mmol) and tert-butyl
isocyanide (166 mg, 226 l, 2 mmol) were added to anhydrous MeCN (2 mL) and heated at reflux under an
atmosphere of nitrogen for 24 h. Excess solvent was removed under reduced pressure and the crude product was
purified by column chromatography (2:1 Petrol:EtOAc) to yield 25c as a colourless oil (40 mg, 6 %); Rf 0.19
(2:1 Petrol:EtOAc); IR (thin film) max 3330 (br), 2974, 2905, 2865, 1662, 1515, 1480, 1454 cm-1; 1H NMR
(CDCl3, 300 MHz)  1.32 (9H, s, t-Bu), 1.91-2.04 (1H, bs, NH), 2.37 (3H, s, Ar-CH3), 2.84 (2H, m, S-CH2),
3.02-3.08 (2H, m, NH-CH2), 3.97 (1H, s, CH), 7.13- 7.37 (9H, m, Ar-H); 13C NMR (75 MHz, CDCl3)  21.2,
28.7, 34.5, 47.2, 50.7, 67.7, 126.4, 127.0, 129.0, 129.5, 129.7, 131.8, 136.7, 137.6, 171.2; HRMS: [M+H]+,
C21H29N2OS requires 357.20006, found 357.20142.
3.6.5. 2-{Methyl[2-(5-phenyltetrazol-1-yl)ethyl]amino}octanoic acid tert-butylamide 26a.
Oxazolidine 1b (343 mg, 2 mmol), 5-phenyl-1H-tetrazole (292 mg, 2 mmol), TsOH (19 mg, 0.1 mmol) and tert-
butyl isocyanide (226 µl, 2 mmol) were added to anhydrous MeCN (5 mL) at rt and then heated at reflux under
an atmosphere of nitrogen for 24 h. Excess solvent was removed under reduced pressure and the crude product
was purified by column chromatography (80:10:1 Petrol:EtOAc:Et3N) to yield 26a as a colourless oil (565 mg,
71 %); Rf 0.35 ( 90:30:1 Petrol:EtOAc:Et3N); IR (thin film) max 3335 (br), 2955, 2920, 2862, 1665, 1518, 1460
cm-1; 1H NMR (CDCl3)  0.74 (3H, t, J 6.8 Hz, CH2CH3), 1.11 (9H, s, t-Bu), 1.16-1.28 (8H, m, alkyl), 1.33-1.44
(1H, m, alkyl), 1.57-1.68 (1H, m, alkyl), 2.17 (3H, s, N-CH3), 2.76 (1H, dd, J 7.1, 5.8 Hz, CH), 3.03 (1H, ddd, J
13.6, 7.0, 5.2 Hz, CH3NCHH), 3.13 (1H, ddd, J 13.6, 7.0, 5.2 Hz, CH3NCHH), 4.58 (1H, ddd, J 13.9, 7.0, 5.2
Hz, N-CHH), 4.67 (1H, ddd, J 13.9, 7.0, 5.1 Hz, N-CHH), 6.26 (1H, s , NH), 7.31-7.39 (3H, m, Ar), 8.00-8.05
(2H, m, Ar); 13C NMR (CDCl3)  14.0, 22.5, 27.0, 27.4, 28.5, 29.2, 31.6, 37.3, 50.3, 51.3, 53.9, 68.6, 126.7,
20
127.3, 128.8, 130.3, 165.0, 171.6; HRMS (CI): [M+H]+, C22H37N6O requires 401.30287, found 401.30378;
LRMS (CI): 401 (100, M+H), 300 (80), 104 (53), 402 (26), 255 (23), 272 (20).
3.6.6. N-tert-Butyl-2-(methyl(2-(5-phenyl-2H-tetrazol-2-yl)ethyl)amino)-2-p-tolylacetamide 26b.
Oxazolidine 1a (355 mg, 2 mmol), 5-phenyl-1H-tetrazole (292 mg, 2 mmol), TsOH (19 mg, 0.1 mmol) and tert-
butyl isocyanide (226 µl, 2 mmol) were added to anhydrous MeCN (5 mL) at rt and then heated at reflux under
an atmosphere of nitrogen for 24 h. Excess solvent was removed under reduced pressure and the crude product
was purified by column chromatography (80:10:1 Petrol:EtOAc:Et3N) to yield 26b as a colourless oil (441 mg,
67 %); Rf 0.11 90:30:1 (Petrol:EtOAc:Et3N); IR (thin film) max 3190 (br), 2966, 2873, 1668, 1514, 1466, 1452
cm-1; 1H NMR (CDCl3)  1.56 (9H, s, t-Bu), 2.26 (3H, s, N-CH3), 2.33 (3H, s, tolyl-CH3), 2.85-2.92 (1H, m,
CH3NCHH), 2.99 (1H, m, CH3NCHH), 3.84 (1H, s, CH), 4.62-4.68 (1H, m, N-CHH), 4.72-4.81 (1H, m, N-
CHH), 6.61 (1H, s , NH), 6.92 (2H, d, J 8.2 Hz, Ar), 7.02 (2H, d, J 7.8 Hz, Ar), 7.49-7.60 (3H, m, Ar), 8.13-
8.16 (2H, m, Ar); 13C NMR (CDCl3)  21.1, 28.5, 40.1, 50.7, 51.1, 53.1, 75.4, 126.8, 127.4, 128.8, 128.9, 129.3,
130.4, 132.6, 137.9, 165.2, 170.3; HRMS (ES+): [M+H]+, C23H31N6O requires 407.25593, found 407.25580;
LRMS (ES): 407 (100, M+H), 429 (39, M+Na), 408 (26), 430 (8), 379 (7).
3.6.7. N-tert-Butyl-5-(5-phenyl-2H-tetrazol-2-yl)-2-(pyrrolidin-1-yl) pentanamide 29a and N-tert-butyl-5-
(5-phenyl-1H-tetrazol-1-yl)-2-(pyrrolidin-1-yl) pentanamide 29b, (15:1 Mixture).
1-(Tetrahydrofuran-2-yl)pyrrolidine 27 (282 mg, 2 mmol), 5-phenyl-1H-tetrazole (292 mg, 2 mmol), TsOH (8
mg, 0.04 mmol) and tert-butyl isocyanide (226 l, 2 mmol) were added to anhydrous MeCN (2mL) and heated
at reflux for 42 h under an atmosphere of N2. Excess solvent was removed under reduced pressure and the
residue was purified by flash column chromatography (2:1 Petrol:EtOAc) to give 29a and 29b (15:1 mixture) as
a colourless oil (548 mg, 74%). Rf 0.23 (2:1 Petrol:EtOAc); IR (thin film) max 3335 (br), 2964, 2888, 1663,
1520, 1464, 1450 cm-1; 29a: 1H NMR (CDCl3, 500 MHz)  1.28 (9H, s, t-Bu), 1.48-1.57 (1H, m, CHCHH),
1.65-1.69 (4H, m, CH2-CH2), 1.69-1.77 (1H, m, CHCHH), 2.01-2.08 (1H, m, CHH), 2.08-2.18 (1H, m, CHH),
2.38-2.44 (4H, m, CH2-N-CH2), 2.62 (1H, dd, J 8.7, 4.3 Hz, CH), 4.60 (1H, ddd, J 13.6, 8.2, 6.9 Hz, N-CHH),
4.64 (1H, ddd, J 13.6, 8.2, 6.9, Hz, N-CHH), 6.54 (1H, bs, NH), 7.38-7.42 (3H, m, Ar), 8.06 (2H, dd, J 8.2, 1.9
Hz, Ar); 29b: 1H NMR (CDCl3, 500 MHz)  1.24 (9H, s, t-Bu), 1.48-1.57 (1H, m, CHHCH2N), 1.65-1.69 (4H,
m, CH2-CH2), 1.69-1.77 (1H, m, CHCHH), 2.01-2.08 (1H, m, CHH), 2.08-2.18 (1H, m, CHH), 2.38-2.44 (4H,
m, CH2-N-CH2), 2.52 (1H, dd, J 8.8, 4.5 Hz, CH), 4.38-4.43 (2H, m, N-CH2), 6.52 (1H, bs, NH), 7.46-7.50 (3H,
m, Ar), 7.61-7.65 (2H, m, Ar); 29a: 13C NMR (CDCl3, 125 MHz)  23.06, 25.3, 28.46, 28.53, 51.3, 52.7, 60.13,
68.9, 126.6, 127.3, 128.7, 130.0, 164.8, 171.83; 29b: 13C NMR (CDCl3, 125 MHz)  23.06, 25.8, 28.46, 28.50,
47.6, 51.2, 60.13, 68.7, 123.8, 128.5, 129.1, 131.1, 154.1, 171.72; HRMS (CI): [M+H]+, C20H31N6O requires
371.25592, found 371.25524; LRMS (CI): 270 (100, M+H), 371 (88, M+H), 104 (64), 225 (41), 173 (27), 189
(25).
3.6.8. N-tert-Butyl-2-morpholino-6-(5-phenyl-2H-tetrazol-2-yl)hexanamide 30a (major) and N-tert-butyl-
2-morpholino-6-(5-phenyl-1H-tetrazol-1-yl)hexanamide 30b (minor), (10:1 Mixture).
4-(Tetrahydro-2H-pyran-2-yl)morpholine 28 (342 mg, 2 mmol), 5-phenyl-1H-tetrazole (292 mg, 2 mmol), TsOH
(8 mg, 0.04 mmol) and tert-butyl isocyanide (226 l, 2 mmol) were added to anhydrous MeCN (2mL) and
heated at reflux for 18 h under an atmosphere of N2. Excess solvent was removed under reduced pressure and
the residue was purified by flash column chromatography (90:10:1 Petrol:EtOAc:Et3N) to give 30a and 30b
(10:1 Mixture) as a colourless oil (663 mg, 83%); Rf 0.44 (90:10:1 Petrol:EtOAc:Et3N); IR (thin film) max 3320
(br), 2963, 2952, 2863, 1663, 1533, 1464, 1452 cm-1. 30a: 1H NMR (CDCl3)  1.16 (9H, s, t-Bu), 1.22-1.1.37
(2H, m, CH2), 1.39-1.48 (2H, m, CHCH2), 1.78-1.86 (2H, m, CH2), 2.27-2.41 (4H, m, CH2-N-CH2), 2.55 (1H, t,
J 6.7 Hz, CH), 3.55 (4H, t, J 4.8 Hz, CH2-O-CH2), 4.26 (2H, t, J 7.2 Hz, N-CH2), 6.62 (1H, bs, NH), 7.38-7.42
(3H, m, Ar), 7.49-7.54 (2H, m, Ar). 30b: 1H NMR (CDCl3)  1.17 (9H, s, t-Bu), 1.22-1.1.37 (2H, m, CH2), 1.50-
1.59 (2H, m, CHCH2), 1.88-2.00 (2H, m, CH2), 2.27-2.41 (4H, m, CH2-N-CH2), 2.55 (1H, t, J 6.7 Hz, CH), 3.55
(4H, t, J 4.8 Hz, CH2-O-CH2), 4.50 (2H, t, J 7.0 Hz, N-CH2), 6.61 (1H, bs, NH), 7.28-7.37 (3H, m, Ar), 7.96-
7.99 (2H, m, Ar). 30a: 13C NMR (CDCl3, )  23.2, 27.2, 28.6, 29.3, 50.54, 52.7, 67.06, 69.5, 126.6, 127.4, 128.8,
130.1, 164.8, 171.2; 30b: 13C NMR (CDCl3)  23.4, 27.0, 28.6, 29.5, 47.7, 50.54, 67.06, 69.3, 123.8, 128.6,
129.2, 131.1, 154.2, 170.9; HRMS (FAB): [M+H]+, C21H33N6O2 requires 401.26649, found 401.26566; LRMS
(FAB): 154 (100), 401 (62, M+H), 155 (24), 153 (15), 307 (14), 402 (13).
3.6.9. N-tert-Butyl-2-methyl-2-phenylamino-4-phenylsulfanylbutyramide 34.
4-Hydroxybutanone (172 l, 2 mmol), benzylamine (219 l, 2 mmol), thiophenol (205 l, 2 mmol), TsOH (4
mg, 0.02 mmol) and tert-butyl isocyanide (226 l, 2 mmol) were added to anhydrous MeCN (5 mL) and heated
at 45 °C for 18 h under an atmosphere of N2. Excess solvent was removed under reduced pressure and the
residue was purified by flash column chromatography (7:1 Petrol:EtOAc) to give 34 (373 mg, 53 %) as a pale
yellow oil Rf 0.32 (2:1 Petrol:EtOAc); IR (thin film) max 3345 (br), 3012, 2998, 2887, 2952, 2913, 1668, 1583,
1480, 1439 cm-1; 1H NMR (CDCl3)  1.34 (9H, s, t-Bu), 1.37 (3H, s, CH3), 1.97-2.04 (2H, m, CH2), 2.14 (1H, s,
NH), 2.91 (1H, ddd, J 13.1, 9.9, 6.4 Hz, S-CHH), 2.98 (1H, ddd, J 13.1, 9.9, 6.7 Hz, S-CHH), 3.53 (1H, d, J 12.6
Hz, ArCHH), 3.68 (1H, d, J 12.6 Hz, Ar-CHH), 7.13 (1H, tt, J 6.2, 1.5 Hz, Ar), 7.25-7.39 (10H, m, Ar + NH);
21
13C NMR (CDCl3)  22.5, 28.6, 28.8, 38.6, 47.5, 50.4, 62.0, 126.1, 127.3, 127.9, 128.7, 129.0, 129.1, 129.2,
136.2, 140.0, 174.0; HRMS (EI): [M+H]+, C22H31N2OS requires 371.21571, found 371.21583; LRMS (EI): 371
(100 M+H), 372 (22), 393 (20, M+Na), 212 (8), 270 (6), 395 (5).
3.6.10. 2-(Benzylamino)-N-tert-butyl-2-methyl-4-(5-phenyl-2H-tetrazol-2-yl)butanamide 35.
4-Hydroxybutanone (172 l, 2 mmol), benzylamine (219 l, 2 mmol), 5-phenyl-1H-tetrazole (292 mg, 2 mmol),
TsOH (4 mg, 0.02 mmol) and tert-butyl isocyanide (226 l, 2 mmol) were added to iPrOH (5 mL) and heated at
45 °C for 18 h under an atmosphere of N2. Excess solvent was removed under reduced pressure and the residue
was purified by flash column chromatography (4:1 Petrol:EtOAc) to give 35 as a colourless oil (211 mg, 26 %)
Rf 0.36 (2:1 Petrol:EtOAc); IR (thin film) max 3370 (br), 3048, 3007, 2953, 2937, 2867, 1661, 1516, 1451, 1362
cm-1; 1H NMR (CDCl3)  1.38 (9H, s, t-Bu), 1.46 (3H, s, CH3), 2.41 (1H, ddd, J 14.2, 8.7, 6.2 Hz, CHH), 2.50
(1H, ddd, J 14.2, 8.5, 7.0 Hz, CHH), 3.55 (1H, d, J 12.7 Hz, Ar-CHH), 3.68 (1H, d, J 12.7 Hz, Ar-CHH), 4.70
(1H, ddd, J 13.8 8.6, 6.2 Hz, N-CHH), 4.87 (1H, ddd, J 13.8, 8.7, 7.0 Hz, N-CHH), 7.19-7.25 (5H, m, Ar), 7.41
(1H, bs, NH), 7.44-7.49 (3H, m, Ar), 8.06-8.14 (2H, m, Ar); 13C NMR (CDCl3)  23.1, 28.7, 37.7, 47.5, 49.6,
50.7, 61.4, 126.8, 127.3, 127.4, 127.7, 128.6, 128.9, 130.3, 139.5, 165.1, 173.4; HRMS (EI): [M+H]+,
C23H30N6O requires 407.25593, found 407.25612; LRMS (EI): 407 (100 M+H), 360 (92), 338 (54), 429 (30),
317 (27), 261 (22).
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